Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
A 2025 randomized, double-blind, placebo-controlled trial published in Clinical Nutrition found that 15 mg/day of hydroxytyrosol improved antioxidant and anti-inflammatory status in overweight individuals with prediabetes over 16 weeks, while preserving insulin sensitivity (Moratilla-Rivera et al., 2025)
Psychoses and related disorders (Treatment summaries)
Q: Can I combine it with other IV therapies
It is still under investigation and has not yet entered Phase 3 obesity trials in the UK
Speeding up Recovery and Healing: Whether it's a minor injury, aches and pains from physical activity, or the wear and tear of everyday life, BPC-157 has the remarkable ability to accelerate the healing process
Weeks 5-8: The Building Phase (0.5 mg) After four weeks, your healthcare provider will typically increase your dose to 0.5 mg weekly
